Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01242878
What this trial is testing

MACS Study - Microparticles and Coagulation in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
University College, London 360
Testing effectiveness (Phase 2)Looking for participantsNCT07681089
What this trial is testing

Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia

Who this might be right for
Liver Cirrhosis
Kiminori Kimura, MD 4
Post-approval studies (Phase 4)UnknownNCT06320626
What this trial is testing

Pharmacokinetic-guided Dosing of Emicizumab

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A, Severe+3 more
Kathelijn Fischer 95
Large-scale testing (Phase 3)Study completedNCT01863758
What this trial is testing

Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

Who this might be right for
Severe Haemophilia A
Octapharma 66
Not applicableStudy completedNCT00798499
What this trial is testing

A Feasibility Study to Collect Data in Patients With Haemophilia

Who this might be right for
Hemophilia
AstraZeneca 50
Large-scale testing (Phase 3)Study completedNCT00037544
What this trial is testing

Study Evaluating ReFacto AF in Severe Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Study completedNCT03205163
What this trial is testing

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

Who this might be right for
Hemophilia A
Bioverativ, a Sanofi company 16
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Not applicableUnknownNCT02116855
What this trial is testing

Individualized Prophylaxis for Severe Hemophilia A Children

Who this might be right for
Hemophilia
Beijing Children's Hospital 50
Not applicableStudy completedNCT01269138
What this trial is testing

Treatment of Inherited Factor VII Deficiency

Who this might be right for
Factor VII Deficiency
University of L'Aquila 223
Not applicableActive Not RecruitingNCT04158934
What this trial is testing

A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 207
Not applicableStudy completedNCT03914716
What this trial is testing

Imaging of Arthropathy in Boys With Hemophilia in China

Who this might be right for
Hemophilia
Andrea Doria 49
Not applicableStudy completedNCT03070912
What this trial is testing

Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients

Who this might be right for
Von Willebrand Diseases
University Hospital, Lille 257
Testing effectiveness (Phase 2)Looking for participantsNCT07644832
What this trial is testing

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

Who this might be right for
Hemophilia AHemophilia BFactor VII Deficiency
Shanghai RAAS Blood Products Co., Ltd. 76
Early research (Phase 1)Study completedNCT06579144
What this trial is testing

Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

Who this might be right for
Hemophilia A
Swedish Orphan Biovitrum 24
Not applicableLooking for participantsNCT07523399
What this trial is testing

Joint Health, Balance and Quality of Life in Adults With Hemophilia A

Who this might be right for
Hemophilia A
Yuzuncu Yil University 36
Large-scale testing (Phase 3)Study completedNCT00719563
What this trial is testing

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+7 more
Alliance for Clinical Trials in Oncology 364
Not applicableStudy completedNCT00112593
What this trial is testing

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more
Fred Hutchinson Cancer Center 5
Not applicableStudy completedNCT02476942
What this trial is testing

A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment

Who this might be right for
Hemophilia A
Hoffmann-La Roche 221
Early research (Phase 1)Study completedNCT00104923
What this trial is testing

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+1 more
California Cancer Consortium 29
Next Page